Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00300430
Status:
COMPLETED
Last Update Posted:
2009-07-23
First Post:
2006-03-07
Brief Title:
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335 in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Long-Term Open-Label Safety Extension Study of the Combination of Fenofibric Acid and Statin Therapy for Subjects With Mixed Dyslipidemia
Status:
COMPLETED
Status Verified Date:
2009-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to test the safety and the effects of using an investigational drug regimen once daily ABT-335 Investigational drug administered in combination with once daily atorvastatin calcium rosuvastatin calcium or simvastatin in patients with abnormal lipid levels in the blood
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None